The Metabolic Health Study

This clinical study is evaluating a potential new weight loss drug for obesity. Obesity is a growing health concern and increases the risk of conditions such as diabetes, heart disease, stroke, cancer, and mental health disorders. The study drug is designed to help regulate appetite, digestion, and blood sugar levels. The study is a randomised, double-blind, placebo-controlled trial. The purpose of this study is to assess the safety and tolerability of a single dose in healthy men and women with a BMI of 25–40.